How does a medicine get from the lab to patients?

A pioneer in cancer care treatment, oncologist Lennie Sender has a deep understanding of both the possibilities and limitations of harnessing the immune system to treat different types of cancer.

Researchers have built a robot made up of individual ‘particles’ that moves with no centralized control. The bots rely on the same kind of statistical mechanics that allows groups of cells to move, creating some intriguing possibilities.

Antibody-drug conjugates or ADCs represent an innovative therapeutic application that combines the unique properties of monoclonal antibodies (mAbs) with the potent cell killing activity of cytotoxic small molecule drugs.